Quarterly report pursuant to Section 13 or 15(d)

JT Pharmaceuticals Asset Purchase Agreement (Details)

v3.22.1
JT Pharmaceuticals Asset Purchase Agreement (Details) - JT Pharmaceuticals - USD ($)
1 Months Ended
Jan. 31, 2022
Oct. 31, 2020
Asset Purchase Agreement [Line Items]    
Closing payment   $ 15,000,000
Milestone Payments $ 100,000  
Issuance of common stock, net (in shares) 51,021